ARCHIVES

Health Reform Bill Contains Unpleasant Surprises For Drug Manufacturers

This article is from The Cancer Letter archive.

Vol. 19 No. 43 | November 5, 1993

Download PDF Visit The Full Archive

Related Articles

DCCR Cancer Information Systems Program Renewed For Three More Years; Two Dropped, Two Added

September 1, 1978

DCPC Suggest Options For Encouraging New Minority Centers

May 4, 1984

Sharp To Direct New Institute For Brain Research At MIT.

March 3, 2000

NCI Cooperative Group, Cancer Center Trials Listed

September 30, 2005

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

May 27, 2011

In Brief: Fauci, Washington Univ. Chancellor, Merck Chairman Reportedly On Final NIH Director List

August 25, 1989